BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2554724)

  • 1. Oral contraceptive use and liver cancer.
    Palmer JR; Rosenberg L; Kaufman DW; Warshauer ME; Stolley P; Shapiro S
    Am J Epidemiol; 1989 Nov; 130(5):878-82. PubMed ID: 2554724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use.
    Rooks JB; Ory HW; Ishak KG; Strauss LT; Greenspan JR; Hill AP; Tyler CW
    JAMA; 1979 Aug; 242(7):644-8. PubMed ID: 221698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of primary liver tumors and oral contraceptive use.
    Vana J; Murphy GP; Aronoff BL; Baker HW
    J Toxicol Environ Health; 1979; 5(2-3):255-73. PubMed ID: 224198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of the data collection process for a multicenter, population-based, case-control design.
    Wingo PA; Ory HW; Layde PM; Lee NC
    Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign hepatocellular tumors.
    Guzman IJ; Gold JH; Rosai J; Schneider PD; Varco RL; Buchwald H
    Surgery; 1977 Oct; 82(4):495-503. PubMed ID: 197654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female hormone utilisation and risk of hepatocellular carcinoma.
    Tavani A; Negri E; Parazzini F; Franceschi S; La Vecchia C
    Br J Cancer; 1993 Mar; 67(3):635-7. PubMed ID: 8382515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of liver neoplasia in relation to combined oral contraceptive use.
    Rosenberg L
    Contraception; 1991 Jun; 43(6):643-52. PubMed ID: 1651205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer before age 45 and oral contraceptive use: new findings.
    Miller DR; Rosenberg L; Kaufman DW; Stolley P; Warshauer ME; Shapiro S
    Am J Epidemiol; 1989 Feb; 129(2):269-80. PubMed ID: 2912040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-control study of oral contraceptive use and risk of breast cancer.
    Rosenberg L; Palmer JR; Rao RS; Zauber AG; Strom BL; Warshauer ME; Harlap S; Shapiro S
    Am J Epidemiol; 1996 Jan; 143(1):25-37. PubMed ID: 8533744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma in women: probable lack of etiologic association with oral contraceptive steroids.
    Goodman ZD; Ishak KG
    Hepatology; 1982; 2(4):440-4. PubMed ID: 6284630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A rare form of benign tumor of the liver possibly related to the use of oral contraceptives: focal pediculated nodular hyperplasia].
    Brouquet J; Chameaud J; Vire O; Fabre P; Catanzano G; Baudet JH
    Rev Fr Gynecol Obstet; 1985; 80(8-9):621-7. PubMed ID: 2997901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign hepatic tumors and oral contraceptive pills.
    Kalra TM; Mangla JC; DePapp EW
    Am J Med; 1976 Dec; 61(6):871-7. PubMed ID: 188336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma and oral contraceptives.
    Henderson BE; Preston-Martin S; Edmondson HA; Peters RL; Pike MC
    Br J Cancer; 1983 Sep; 48(3):437-40. PubMed ID: 6311235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer risk and oral contraceptive use: results from a large case-control study.
    Weinstein AL; Mahoney MC; Nasca PC; Leske MC; Varma AO
    Epidemiology; 1991 Sep; 2(5):353-8. PubMed ID: 1742384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma.
    Gordon SC; Reddy KR; Livingstone AS; Jeffers LJ; Schiff ER
    Ann Intern Med; 1986 Oct; 105(4):547-9. PubMed ID: 3019201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parity and primary liver cancer among young women.
    Hsing AW; McLaughlin JK; Hoover RN; Co Chien HT; Blot WJ; Fraumeni JF
    J Natl Cancer Inst; 1992 Jul; 84(14):1118-9. PubMed ID: 1619686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer of the liver and the use of oral contraceptives.
    Forman D; Vincent TJ; Doll R
    Br Med J (Clin Res Ed); 1986 May; 292(6532):1357-61. PubMed ID: 3011186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the role of oral contraceptive use in the etiology of benign and malignant liver tumors.
    Mettlin C; Natarajan N
    J Surg Oncol; 1981; 18(1):73-85. PubMed ID: 6270469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives as related to cancer and benign lesions of the breast.
    Fasal E; Paffenbarger RS
    J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.